Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet
Status: | Completed |
---|---|
Healthy: | No |
Age Range: | 12 - Any |
Updated: | 11/30/-0001 |
Start Date: | September 2012 |
End Date: | June 2013 |
Contact: | Pfizer CT.gov Call Center |
Phone: | 1-800-718-1021 |
Ibuprofen 600 mg Immediate Release/Extended Release (IR/ER) Caplet Self-Selection, Safety and Compliance Study
A self-selection and actual use trial to evaluate the extent to which consumers will
appropriately select and use the 600 mg immediate release/extended release caplets and
comply with dosing instructions.
Inclusion Criteria:
- at least 12 years of age
- use of at least 5 doses per month of over-the-counter pain relievers over the past 3
months
- provide written informed consent (subjects 12-<18 years of age provide a written
assent and parent/guardian will provide written informed consent)
- capable of and willing to swallow the study medication
Exclusion Criteria:
- participated in other research studies in the last 6 months
- they or someone else in their household work for a pharmaceutical company, is a
relative of study site personnel involved with the study, or an immediate family
member is already enrolled in the study
- have a history of known allergies to ibuprofen, aspirin, or other NSAIDs
- have a history of heart surgery in the last 60 days or planned heart surgery in the
next 60 days
- female subjects are pregnant or breast feeding
We found this trial at
10
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials